|Articles|July 21, 2022
Sharp Announces Partnership With ClinsChain
Partnership will expand Sharp's reach to China.
Advertisement
Sharp has formed a strategic partnership with China-based ClinsChain to expand its reach into the Chinese market.
The partnership will enable Sharp to offer pharma clients local expertise for their clinical studies while benefiting from the efficiency of an established reciprocal service offering between Sharp and ClinsChain.
Read more about the partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
Obesity Trials: Scaling Operations for High-Demand Therapeutics
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
